Avmacol BR has been shown to induce, activate, and stimulate protective enzymes in our cells capable of detoxifying harmful estrogen mimickers and quinone estrogen metabolites thus helping to promote and support breast health.▲*
▲ In laboratory cell culture studies using RAW 264.7 macrophage cells, the genes encoding
the enzymes quinone oxidoreductase (NQO1) and UDP-glucuronosyltransferase1A1 (UGT1A1)
were induced with the combination of actives delivered by Avmacol BR. In vivo studies
demonstrate the genes encoding UGT1A1 and Hemoxygenase-1 (HMOX1) were induced with
the combination of actives delivered by Avmacol BR in Sprague Dawley mammary tissue.